Yes, intertumoral heterogeneity can impact a patient's prognosis. Tumors with a high degree of heterogeneity may be more aggressive and resistant to treatment, leading to poorer outcomes. Conversely, understanding the specific characteristics of a tumor can help in predicting its behavior and response to therapy, thereby aiding in prognostication.
